• 
  Thibaud Charrier, Nadia Haddy, Brice Fresneau, Boris Schwartz, Neige Journy, et al.. Life years lost by childhood cancer treatment and health related late effects among childhood cancer survivors. Cancer Epidemiology, 2024, 93, ⟨10.1016/j.canep.2024.102692⟩. ⟨hal-04781953⟩
• 
  Pietro Lapidari, Arnauld Gbenou, Julie Havas, Elise Martin, Barbara Pistilli, et al.. Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer. The Breast, 2021, 57, pp.43-48. ⟨10.1016/j.breast.2021.02.014⟩. ⟨hal-04769597⟩
• 
  C.S. Groeneveld, C. Pfister, S. Culine, V. Harter, C. Krucker, et al.. Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial. Annals of Oncology, 2024, ⟨10.1016/j.annonc.2024.09.008⟩. ⟨hal-04780573⟩
• 
  Juliette Thariat, Florent Carsuzaa, Arnaud Beddok, Sophie Deneuve, Pierre-Yves Marcy, et al.. Reconstructive flap surgery in head and neck cancer patients: an interdisciplinary view of the challenges encountered by radiation oncologists in postoperative radiotherapy. Frontiers in Oncology, 2024, 14, pp.1379861. ⟨10.3389/fonc.2024.1379861⟩. ⟨hal-04564034⟩
• 
  Francois Gouin, Audrey Michot, Mehrdad Jafari, Charles Honoré, Jean Camille Mattei, et al.. Improved metastatic-free survival after systematic re-excision following complete macroscopic unplanned excision of limb or trunk soft tissue sarcoma. Cancers, 2024, 16 (7), pp.1365. ⟨10.3390/cancers16071365⟩. ⟨hal-04653665⟩
• 
  Rayan Kabirian, Maria Alice Franzoi, Julie Havas, Charles Coutant, Olivier Trédan, et al.. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer. JAMA Network Open, 2023, 6 (11), pp.e2343910. ⟨10.1001/jamanetworkopen.2023.43910⟩. ⟨hal-04765786⟩
• 
  Marcela Carausu, Matthieu Carton, Luc Cabel, Anne Patsouris, Christelle Levy, et al.. Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. Therapeutic Advances in Medical Oncology, 2022, 14, pp.175883592210770. ⟨10.1177/17588359221077082⟩. ⟨hal-03867853⟩
• 
  Fabienne Lesueur, Noura Mebirouk, Yue Jiao, Laure Barjhoux, Muriel Belotti, et al.. GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers. Frontiers in Oncology, 2018, 8, pp.490. ⟨10.3389/fonc.2018.00490⟩. ⟨hal-01926758⟩
• 
  Hélène Tubeuf, Sandrine M Caputo, Teresa Sullivan, Julie Rondeaux, Sophie Krieger, et al.. Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System. Cancer Research, 2020, 80 (17), pp.3593-3605. ⟨10.1158/0008-5472.CAN-20-0895⟩. ⟨hal-03597164⟩
• 
  A Di Meglio, J Havas, M Pagliuca, M A Franzoi, D Soldato, et al.. A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance two years later. Annals of Oncology, 2024, S0923-7534 (24), pp.01517-5. ⟨10.1016/j.annonc.2024.07.728⟩. ⟨inserm-04673827⟩

210

207